Changhui Yu

1.4k total citations
54 papers, 1.1k citations indexed

About

Changhui Yu is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changhui Yu has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Physiology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changhui Yu's work include Asthma and respiratory diseases (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Cancer-related gene regulation (5 papers). Changhui Yu is often cited by papers focused on Asthma and respiratory diseases (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Cancer-related gene regulation (5 papers). Changhui Yu collaborates with scholars based in China, United States and Sweden. Changhui Yu's co-authors include Fei Zou, Ying Meng, Xu Li, Xiaojing Meng, Shaoxi Cai, Qiang Shen, Chunqing Cai, Haijin Zhao, Shan Huang and Weibo Luo and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Changhui Yu

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changhui Yu China 16 431 214 186 181 144 54 1.1k
Cinzia Ciccacci Italy 25 492 1.1× 80 0.4× 296 1.6× 171 0.9× 286 2.0× 78 1.6k
Ping Hou China 20 456 1.1× 181 0.8× 399 2.1× 103 0.6× 141 1.0× 98 1.6k
Yu Duan China 26 532 1.2× 191 0.9× 171 0.9× 151 0.8× 227 1.6× 80 1.8k
Yi‐Ping Fu United States 23 753 1.7× 281 1.3× 80 0.4× 209 1.2× 193 1.3× 60 1.5k
Kun‐Ling Ma China 24 933 2.2× 158 0.7× 212 1.1× 103 0.6× 223 1.5× 60 1.7k
Zhanmei Zhou China 23 743 1.7× 193 0.9× 175 0.9× 133 0.7× 313 2.2× 46 1.6k
Alex Gutsol Canada 17 739 1.7× 144 0.7× 314 1.7× 245 1.4× 240 1.7× 38 1.5k
Thomas J. Raife United States 23 308 0.7× 129 0.6× 331 1.8× 343 1.9× 51 0.4× 67 1.5k
Ioan C. Cucoranu United States 8 382 0.9× 119 0.6× 204 1.1× 215 1.2× 63 0.4× 12 925
Yi Song China 19 456 1.1× 231 1.1× 98 0.5× 52 0.3× 170 1.2× 88 1.1k

Countries citing papers authored by Changhui Yu

Since Specialization
Citations

This map shows the geographic impact of Changhui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhui Yu more than expected).

Fields of papers citing papers by Changhui Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changhui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhui Yu. The network helps show where Changhui Yu may publish in the future.

Co-authorship network of co-authors of Changhui Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Changhui Yu. A scholar is included among the top collaborators of Changhui Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changhui Yu. Changhui Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Yanqing, Qian Zhang, Yanyan Ma, et al.. (2024). Inhibition of xanthine oxidase by allopurinol suppresses HMGB1 secretion and ameliorates experimental asthma. Redox Biology. 70. 103021–103021. 19 indexed citations
2.
Tang, Wei, Lixuan Chen, Changhui Yu, et al.. (2024). Lead inhibits microglial cell migration via suppression of store-operated calcium entry. Toxicology Letters. 393. 69–77. 2 indexed citations
3.
Zhou, Zili, Jinming Zhang, Xiaojing Meng, et al.. (2023). TGF-β1 promotes SCD1 expression via the PI3K-Akt-mTOR-SREBP1 signaling pathway in lung fibroblasts. Respiratory Research. 24(1). 8–8. 9 indexed citations
4.
Yu, Changhui, Hong Wu, Jing Kang, et al.. (2023). Cbx4 governs HIF-1α to involve in Th9 cell differentiation promoting asthma by its SUMO E3 ligase activity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(7). 119524–119524. 6 indexed citations
5.
Chen, Ying, Yanhong Wang, Yanyan Ma, et al.. (2023). Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model. Biomedicine & Pharmacotherapy. 162. 114680–114680. 15 indexed citations
6.
Xuan, Jianwei, Haijin Zhao, Hangming Dong, et al.. (2022). Newly diagnosed asthma in China: initial severity and changes over a 1-year management period. Annals of Translational Medicine. 10(2). 75–75. 3 indexed citations
7.
Zhou, Zili, Jiayuan Liang, Haijin Zhao, et al.. (2022). Blockade of CBX4-mediated β-catenin SUMOylation attenuates airway epithelial barrier dysfunction in asthma. International Immunopharmacology. 113(Pt A). 109333–109333. 13 indexed citations
8.
Zhou, Zili, Hangming Dong, Fei Zou, et al.. (2022). CBX4 Regulates Long-Form Thymic Stromal Lymphopoietin–mediated Airway Inflammation through SUMOylation in House Dust Mite–induced Asthma. American Journal of Respiratory Cell and Molecular Biology. 66(6). 648–660. 14 indexed citations
10.
Zhong, Shaobo, et al.. (2021). Efficacy and safety of Jinshuibao capsule combined with beclomethasone propionate in the treatment of bronchial asthma. Minerva Surgery. 77(3). 299–301. 1 indexed citations
11.
Huang, Shuyu, Xiaoli Zeng, Yafei Yuan, et al.. (2020). Prediction of clinical response to omalizumab in moderate-to-severe asthma patients using the change in total serum IgE level. Journal of Thoracic Disease. 12(12). 7097–7105. 10 indexed citations
12.
Lin, Yun, Jing Xiong, Yanhong Wang, et al.. (2018). RAGE mediates β-catenin stabilization via activation of the Src/p-Cav-1 axis in a chemical-induced asthma model. Toxicology Letters. 299. 149–158. 13 indexed citations
14.
Yu, Changhui, Wei Tang, Yuhao Wang, et al.. (2016). Downregulation of ACE2/Ang-(1–7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry. Cancer Letters. 376(2). 268–277. 91 indexed citations
15.
Yu, Changhui, et al.. (2015). Platelet‐Derived CCL5 Regulates CXC Chemokine Formation and Neutrophil Recruitment in Acute Experimental Colitis. Journal of Cellular Physiology. 231(2). 370–376. 29 indexed citations
16.
Tang, Shihao, Qiang Shen, Xinyi Yang, et al.. (2015). Mitochondrial Ca2+ uniporter is critical for store-operated Ca2+ entry-dependent breast cancer cell migration. Biochemical and Biophysical Research Communications. 458(1). 186–193. 100 indexed citations
18.
Yu, Changhui, Mohammed Merza, Lingtao Luo, & Henrik Thorlacius. (2014). Inhibition of Ras signalling reduces neutrophil infiltration and tissue damage in severe acute pancreatitis. European Journal of Pharmacology. 746. 245–251. 19 indexed citations
19.
Lu, Pan, et al.. (2013). The Influence of Training Step on Price Forecasting Based on Back Propagation Neural Network. International Conference on Multimedia Information Networking and Security. 785–788. 1 indexed citations
20.
Luo, Weibo, Ying Meng, Hongli Ji, et al.. (2012). Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat. PLoS ONE. 7(3). e34230–e34230. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026